Nofazinlimab (Anti-PDCD1 / PD-1 / CD279)

Nofazinlimab (anti-PDCD1/ PD-1 / CD279) is a humanised IgG4 monoclonal antibody targeting PD-1. Nofazinlimab has the potential to be used in unresectable hepatocellular carcinoma (uHCC) research. MW: 145.08 KD.

• Supplier: Selleck Chemicals
• Product #: A2956
• Sku #: A2956-1mg*5